Wuppertal, Germany

Karl G Metzger


Average Co-Inventor Count = 4.0

ph-index = 16

Forward Citations = 1,219(Granted Patents)


Inventors with similar research interests:


Location History:

  • Wuppertal-Elberfeld, DE (1976 - 1992)
  • Albstadt, DE (1998)
  • Wuppertal, DE (1976 - 2000)

Company Filing History:

goldMedal162 out of 12,157 
 
Bayer Aktiengesellschaft
 patents
silverMedal2 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1976-2000

Loading Chart...
Areas of Expertise:
Quinolone Derivatives
Naphthyridone
Beta-Lactam Antibiotics
Antibacterial Compounds
Cyclopropyl Derivatives
Cephalosporins
Bactericidal Formulations
Amino Acids
Carbacephem Antibiotics
Veterinary Medicine
Pharmaceutical Intermediates
Medicinal Chemistry
163 patents (USPTO):Explore Patents

Title: Karl G Metzger: Pioneering Innovator in Quinolone Derivatives

Introduction:

In the fascinating world of pharmaceutical research and development, Karl G Metzger stands out as a prolific inventor and pioneer in the field of quinolone derivatives. With a remarkable record of 128 patents to his name, Metzger's contributions have significantly advanced the development of antibacterial agents and feed additives. This article delves into his latest patents, career highlights, and collaborations, shedding light on his invaluable contributions to the field.

Latest Patents:

Metzger's recent patents showcase his expertise in developing innovative quinolone derivatives. Two noteworthy inventions include "7-isoindolinyl-quinolone derivatives" and "7-isoindolinyl-naphthyridone." These patents focus on intermediate compounds required for creating novel quinolone derivatives and naphthyridone derivatives. These compounds exhibit a unique substitution pattern at the 7-position, incorporating a partially hydrogenated isoindolinyl ring. Alongside the preparation processes, the patents also emphasize the application of these derivatives as antibacterial agents and feed additives.

Career Highlights:

Karl G Metzger has made significant contributions to the field of pharmaceutical research and development while working at Bayer Aktiengesellschaft, a renowned global company. Throughout his fruitful career, he has innovated multiple pharmaceutical compositions and processes, with his work primarily focusing on quinolone and naphthyridonecarboxylic acid derivatives. Some notable highlights of his career include advancing the synthesis and structural modifications of these compounds, optimizing their antibacterial properties, and exploring their potential applications as therapeutic agents.

Collaborations:

Collaboration plays a critical role in scientific advancement, and Karl G Metzger's work is no exception. Notably, he has collaborated with esteemed colleagues during his tenure at Bayer Aktiengesellschaft. Among his notable coworkers are Hans-Joachim Zeiler and Klaus Grohe. Together, their collaboration has enriched the field of pharmaceutical research, leading to breakthrough inventions and discoveries in antibacterial agents.

Conclusion:

Karl G Metzger's extensive patent portfolio and groundbreaking inventions in quinolone derivatives highlight his exceptional expertise in the field of pharmaceutical research. The development of novel compounds and the optimization of their antibacterial properties underline his commitment to improving human health and animal welfare. Metzger's career achievements, coupled with his fruitful collaborations, demonstrate his invaluable contributions to the field and cement his legacy as an innovator in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…